TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
PharMedCon Europe AB
Closing information (x1000 EUR)
| Closing information | 2025/12 | 2024/12 | 2023/12 |
| Turnover |
70
|
184 | |
| Financial expenses |
0
|
0 | |
| Earnings before taxes |
40
|
144 | |
| EBITDA |
38
|
143 | |
| Total assets |
308
|
289 | |
| Current assets |
72
|
100 | |
| Current liabilities |
5
|
11 | |
| Equity capital |
290
|
268 | |
| - share capital |
4
|
5 | |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Solvency |
94.2%
|
92.7% | |
| Turnover per employee |
70
|
184 | |
| Profit as a percentage of turnover |
57.1%
|
78.3% | |
| Return on assets (ROA) |
13.0%
|
49.8% | |
| Current ratio |
1440.0%
|
909.1% | |
| Return on equity (ROE) |
13.8%
|
53.7% | |
| Change turnover |
-108
|
184 | |
| Change turnover % |
-20%
|
-61% | |
| Chg. No. of employees |
0
|
0
|
1 |
| Chg. No. of employees % |
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.